Credit: Shutterstock photoUnivar, North America's leading chemicals distributor backed by CVC and CD&R, raised $770 million by offering 35 million shares (43% insider) at $22, the high end of the $20-$22 range. At the offer price, Univar commands a fully diluted market cap of $3.1 billion and an enterprise value of $5.9 billion.
Univar will list on the NYSE under the symbol UNVR. Univar initially filed confidentially on n/a. Deutsche Bank, Goldman Sachs, BofA Merrill Lynch, Barclays, Credit Suisse, J.P. Morgan, Jefferies & Co. and Morgan Stanley acted as lead managers on the deal.
The article Univar prices IPO at $22, the high end of the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
